Related Experiment Videos
Treatment noncompliance with orally disintegrating olanzapine tablets
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Integrating Climate Change and Mental Health into Medical Education: A Narrative Review of Interventions and Assessment Tools.
Harvard review of psychiatry·2026
Clozapine Monitoring: Form Follows Function.
Psychiatric services (Washington, D.C.)·2026
Evaluating training and competency assessment in public and community psychiatry: a narrative review.
BMC medical education·2025
Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder: A Multisite, Randomized, Controlled Trial.
The Journal of clinical psychiatry·2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
The American journal of psychiatry·2025
Climate Change Anxiety in Adults with Schizophrenia: a Descriptive Study.
Community mental health journal·2025
Targeting Addiction Treatment Engagement: A Canadian Randomized Effectiveness Trial of Remotely Administered Contingency Management for Treatment Attendance: Cibler l'engagement en matière de traitement des dépendances : essai d'efficacité à répartition aléatoire mené au Canada portant sur la gestion des contingences mise en œuvre à distance pour la participation au traitement.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Mental Illness Prevalence Among Ontario Home Care Clients: Variation by Urban/Rural Residence and Deprivation Measures: Prévalence de la maladie mentale chez les clients de soins à domicile en Ontario : variation selon la résidence urbaine/rurale et les mesures de défavorisation.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Prevalence, Trends and Patterns of ADHD Medication Use Among Children, Adolescents and Young Adults in Quebec, Canada: A Repeated Cross-Sectional Population-Based Study From 2000 to 2022: Prévalence, tendances et profils d'utilisation des médicaments pour le TDAH chez les enfants, les adolescents et les jeunes adultes au Québec (Canada) : étude populationnelle transversale répétée, 2000-2022.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Chronic Health Conditions and Substance Use Among Canadian Youth: A Nationally Representative Study: Problèmes de santé chroniques et usage de substances chez les jeunes Canadiens : étude représentative à l'échelle nationale.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Comparing Health System Costs for Recipients of Minimally Guided Internet-Based Cognitive Behavioural Therapy (iCBT) and Therapist-Guided CBT in Routine Care: A Cohort Study Using Ontario's Linked Health-Administrative Data: Comparaison des coûts pour le système de santé entre les personnes suivant une thérapie cognitivo-comportementale par Internet (TCCI) avec des orientations minimales et les personnes suivant une TCC menée par un ou une thérapeute en soins courants : étude de cohorte utilisant les données administratives de santé liées en Ontario.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Prevalence and Correlates of Depressive Symptoms in Canada During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis Based on 144 Studies Including 406,043 Participants: Prévalence et corrélats des symptômes dépressifs au Canada pendant la pandémie de COVID-19 : revue systématique et méta-analyse de 144 études comprenant 406 043 participants.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas - United States, 2019-2025.
MMWR. Morbidity and mortality weekly report·2026
Rheumatoid Arthritis Guidelines Require Dietary Recommendations: An Overlooked Opportunity.
Clinical nutrition ESPEN·2026
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients.
Drug metabolism and personalized therapy·2026
Benefit-Risk of Voxelotor, Crizanlizumab, and L-Glutamine in Sickle Cell Disease: A Systematic Review.
The American journal of the medical sciences·2026